Kevin C. Osterhoudt, MD, MS cares for injured children as an Attending Physician within the Division of Emergency Medicine at Children’s Hospital of Philadelphia (CHOP) and also serves as Medical Director of CHOP's regional Poison Control Center. With training in pediatrics, pediatric emergency medicine, medical toxicology, and clinical epidemiology, Dr. Osterhoudt is a Professor of Pediatrics at CHOP and the Perelman School of Medicine at the University of Pennsylvania.
In addition to his work as an Associate Fellow with the Center for Injury Research and Prevention at CHOP, Dr. Osterhoudt brings his international perspective on child injury prevention as an Associate Scholar with the Center for Global Health at the University of Pennsylvania.
Dr. Osterhoudt is recognized for teaching excellence and has received the David Cornfeld Bedside Teaching Award from CHOP in 2005, the Scott Mackler Award for Excellence in Teaching from the University of Pennsylvania in 2008, and the ACMT Award for Significant Contributions to the Educational Pursuits of Medical Toxicology from the American College of Medical Toxicology in 2009. In 2016, he was recognized as an Allen R. Cohen Master Clinician at CHOP.
As a nationally recognized advocate on matters of injury and poisoning prevention and on the environmental health of children, Dr. Osterhoudt has served on the Board of Directors of the American College of Medical Toxicology, as the American Board of Pediatrics' representative to the medical toxicology sub-board, and on the Executive Committee of the Council on Environmental Health of the American Academy of Pediatrics. He has co-authored over 175 journal articles, meeting abstracts and textbook chapters and serves on the senior editorial boards of the journals Pediatric Emergency Care and Clinical Toxicology. Recently, Dr. Osterhoudt has been a highly visible advocate for injury prevention with regard to topics such as the opioid epidemic; ingestion of laundry detergent “pods”; button battery ingestion; lamp oil hazards, carbon monoxide exposures; synthetic cannabinoid abuse; and prescription drug abuse.